SecBot SecBot
Insider Cluster (2 insiders) ·Filed Nov 5, 2026

GKOS

GLAUKOS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 7h ago
Insider cluster: 2 insiders, $3.1M total
Actionable Insight • Neutral

The dollar amount is too small to signal a material change in outlook. Monitor next 10-Q for any shift in insider selling patterns or acceleration of share disposals by C-suite officers.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$224.41
T+0 close · Nov 5, 2026 · via day close
Latest settled
+9.50%
T+5 · $245.72
Vs SPY
+6.90%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $224.41entry
  2. T+1 · 8d ago +6.39%α +4.02% · $238.74
  3. T+5 · 4d ago +9.50%α +6.90% · $245.72
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders at Glaukos sold a combined $3.06M in open-market stock within 8 days of the company reporting record Q3 revenue (+58% YoY) and raising FY 2026 guidance. The sales are not under 10b5-1 plans and represent 0.02% of market cap, which is trivial relative to company size.

Key Financial Metrics

Direction
selling
Total Value
$3.1M
Insiders
2

Key Facts

  • Director Kliman Gilbert H sold 2,500 shares at $253 for $633K on 2026-11-04 (no 10b5-1 plan)
  • Chief Development Officer Navratil Tomas sold 10,200 shares at $237.54 for $2.43M on 2026-10-30 (no 10b5-1 plan)
  • Total open-market sales of $3.06M represent ~0.02% of Glaukos' $13.8B market cap
  • Sales occurred 2-8 days after Glaukos reported Q3 record net sales of $211M (+58% YoY) and raised FY 2026 guidance to $775M-$785M

Financial Impact

Total insider sales of $3.06M, negligible relative to $13.8B market cap

Risk Factors

  • Insider sales not under 10b5-1 plans could indicate personal portfolio rebalancing rather than negative outlook
  • No C-suite CEO or CFO selling in this cluster reduces signal significance

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-GKOS-1793925182244

Track record

16 reports on GKOS

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $242.67 Now $244.88 +0.91% settles Nov 23
  2. Nov 12, 20264d ago 144 Neutral 3/10 Entry $245.72 Now $244.88 −0.34% settles Nov 20
  3. Nov 6, 202610d ago 8-K Neutral 3/10 Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
  4. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Viewing Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
  5. Nov 4, 202612d ago 144 Neutral 2/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
  6. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
  7. Oct 30, 202617d ago 144 Neutral 3/10 Entry $237.60 to $224.41 Now $244.88 +3.06% ▼ −5.55% −2.85% vs SPY
  8. Oct 28, 202619d ago 8-K Bullish 6/10 Entry $242.48 to $219.98 Now $244.88 +0.99% ▼ −9.28% −4.55% vs SPY
  9. Aug 13, 202613w ago Insider Cluster Neutral 3/10 Entry $184.53 to $184.89 Now $244.88 +32.70% ▲ +0.20% +1.56% vs SPY
  10. Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $186.63 to $189.55 Now $244.88 +31.21% ▲ +1.56% +2.01% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 6h 39m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026